MCID: PRP009
MIFTS: 34

Peripartum Cardiomyopathy malady

Categories: Rare diseases, Reproductive diseases, Cardiovascular diseases

Aliases & Classifications for Peripartum Cardiomyopathy

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 28ICD10 via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Peripartum Cardiomyopathy:

Name: Peripartum Cardiomyopathy 45 51 65
Postpartum Cardiomyopathy 45 51 65
 
Meadows' Syndrome 45

Characteristics:

Orphanet epidemiological data:

51
postpartum cardiomyopathy:
Age of onset: Adult

Classifications:



External Ids:

Orphanet51 563
ICD10 via Orphanet28 O90.3
UMLS via Orphanet66 C0269972, C0877208
UMLS65 C0269972

Summaries for Peripartum Cardiomyopathy

About this section
Wikipedia:68 Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that is defined as a deterioration... more...

MalaCards based summary: Peripartum Cardiomyopathy, also known as postpartum cardiomyopathy, is related to candidiasis and transmitted_by. An important gene associated with Peripartum Cardiomyopathy is CHRM2 (Cholinergic Receptor Muscarinic 2), and among its related pathways are Antiarrhythmic Pathway, Pharmacodynamics and cAMP signaling pathway. Affiliated tissues include heart, endothelial and liver, and related mouse phenotype muscle.

Related Diseases for Peripartum Cardiomyopathy

About this section

Diseases related to Peripartum Cardiomyopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 407)
idRelated DiseaseScoreTop Affiliating Genes
1candidiasis29.8DRD2, PRL
2transmitted_by11.8
3prostatitis10.4
4breast cancer10.4
5leukemia10.4
6prostate cancer10.3
7esophagitis10.3
8cerebritis10.3
9pancreatitis10.3
10thyroiditis10.3
11lymphoma10.3
12tuberculosis10.3
13pneumonia10.3
14neuronitis10.3
15neurofibromatosis10.3
16retinoblastoma10.2
17arthritis10.2
18japanese encephalitis10.2
19hemolytic-uremic syndrome10.2
20melanoma10.2
21adenocarcinoma10.2
22kidney disease10.2
23encephalitis10.2
24cardiomyopathy10.2
25endotheliitis10.2
26colorectal cancer10.1
27myocardial infarction10.1
28hiv-110.1
29obesity10.1
30sudden infant death syndrome10.1
31renal cell carcinoma10.1
32pick disease10.1
33pancreatic cancer10.1
34burns10.1
35gastric cancer10.1
36ptosis10.1
37arachnoiditis10.1
38cushing's syndrome10.1
39graves' disease10.1
40gonadal dysgenesis10.1
41cervicitis10.1
42endometriosis10.1
43motion sickness10.1
44laryngitis10.1
45retinitis10.1
46hyperglycemia10.1
47myopathy10.1
48rhinitis10.1
49leiomyomatosis10.1
50infertility10.1

Graphical network of the top 20 diseases related to Peripartum Cardiomyopathy:



Diseases related to peripartum cardiomyopathy

Symptoms for Peripartum Cardiomyopathy

About this section

Drugs & Therapeutics for Peripartum Cardiomyopathy

About this section

Drugs for Peripartum Cardiomyopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopamineapprovedPhase 3, Phase 2308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
Bromocriptineapproved, investigationalPhase 3, Phase 22925614-03-331101
Synonyms:
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
2-bromo-α-ergocryptine
2-bromo-α-ergokryptin
2-bromo-α-ergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
AC-13601
AC1L1KXS
AC1Q2716
Alti-Bromocriptine
Apo-Bromocriptine
BIDD:GT0464
BPBio1_001131
BRD-K14496212-001-01-1
Bagren
Biomol-NT_000005
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
Bromocriptine
Bromocriptine (USAN/INN)
Bromocriptine Methanesulfonate
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
 
Bromocriptine methanesulfonate
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CB-154
CCRIS 3244
CHEBI:3181
CHEMBL493
CID31101
Cycloset
D03165
DB01200
EINECS 247-128-5
Ergocryptine, 2-bromo- (8CI)
Ergoset
LS-64540
Lopac0_000171
MolPort-002-512-064
NCGC00024584-04
NCI60_001365
NSC169774
PDSP2_001500
Parlodel
Parlodel Snaptabs
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SPBio_002101
UNII-3A64E3G5ZO
bromocriptine
nchembio873-comp18
3
Heparinapproved, investigationalPhase 37199005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
4
DalteparinapprovedPhase 32819041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Fragmin
Heparin Fragment KABI 2165
Tedelparin
5Neurotransmitter AgentsPhase 3, Phase 214795
6HormonesPhase 3, Phase 211748
7Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
8Hormone AntagonistsPhase 3, Phase 210002
9Dopamine AgonistsPhase 3, Phase 2544
10Antiparkinson AgentsPhase 3, Phase 21312
11Dopamine AgentsPhase 3, Phase 23084
12Heparin, Low-Molecular-WeightPhase 3286
13calcium heparinPhase 3719
14Angiotensin-Converting Enzyme InhibitorsPhase 2634

Interventional clinical trials:

idNameStatusNCT IDPhase
1Bromocriptine in the Treatment of Peripartum CardiomyopathyNot yet recruitingNCT02590601Phase 3
2Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyRecruitingNCT00998556Phase 2
3Investigation in Pregnancy Associate CardiomyopathyCompletedNCT01085955
4Registry and Survey of Women With Pregnancy Related CardiomyopathyRecruitingNCT00273637
5The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE StudyRecruitingNCT02357667

Search NIH Clinical Center for Peripartum Cardiomyopathy

Genetic Tests for Peripartum Cardiomyopathy

About this section

Anatomical Context for Peripartum Cardiomyopathy

About this section

MalaCards organs/tissues related to Peripartum Cardiomyopathy:

33
Heart, Endothelial, Liver, Bone, Breast, Lung, T cells

Animal Models for Peripartum Cardiomyopathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Peripartum Cardiomyopathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.3ADRB1, CHRM2, DRD2, TTN

Publications for Peripartum Cardiomyopathy

About this section

Articles related to Peripartum Cardiomyopathy:

(show top 50)    (show all 494)
idTitleAuthorsYear
1
Kidney cancer: Rest ASSUREd, much can be learned from adjuvant studies in renal cancer. (27108841)
2016
2
Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD. (25320160)
2015
3
Serum Metabolomics in Rats after Acute Paraquat Poisoning. (26133715)
2015
4
IMMUNOGENETICS AND PROGRESSION OF CHRONIC VIRAL HEPATITES]. (26281177)
2015
5
Melatonin and cortisol profiles in patients with pituitary tumors. (25666777)
2015
6
Pyogenic Granuloma: Surgical Treatment with Er:YAG Laser. (25653822)
2014
7
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. (23404727)
2013
8
Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria. (23421884)
2013
9
Ruptured abdominal aortic aneurysm treated by endovascular aneurysm repair under local anaesthesia. (22582560)
2012
10
Sex hormones and cardiac arrest in long QT syndrome: does progesterone represent a potential new antiarrhythmic therapy? (22381742)
2012
11
ID4 is frequently downregulated and partially hypermethylated in prostate cancer. (21882048)
2012
12
The mammalian cone visual cycle promotes rapid M/L-cone pigment regeneration independently of the interphotoreceptor retinoid-binding protein. (21613504)
2011
13
Requirement for proteolysis in spindle assembly checkpoint silencing. (20081372)
2010
14
2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism. (19969063)
2010
15
Testicular contrast harmonic imaging to evaluate intratesticular perfusion alterations in patients with varicocele. (19942233)
2010
16
Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism. (20643388)
2010
17
Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. (20060656)
2010
18
Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. (19261750)
2009
19
Characterization of synovial cell clones isolated from rheumatoid arthritis patients: possible involvement of TNF-alpha in reduction of osteoprotegerin in synovium. (18083042)
2008
20
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. (18614746)
2008
21
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. (18226189)
2008
22
Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. (18037739)
2007
23
Primary liver carcinoma arising in people younger than 30 years. (16146811)
2005
24
Caries risk assessment: methods available to clinicians for caries detection. (16008633)
2005
25
The clear cell adenocarcinoma of the colon: case report and review of the literature. (14557891)
2004
26
A comparative study of O2, CO and CN binding to heme IX protein models. (18007465)
2004
27
Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. (12684587)
2003
28
Identification of the enamelin (g.8344delG) mutation in a new kindred and presentation of a standardized ENAM nomenclature. (12828988)
2003
29
Aspiration pneumonia associated with a giant epiglottic cyst after cardiac surgery. (12826565)
2003
30
Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways. (12423306)
2002
31
The road to squalene synthase. (11969225)
2002
32
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. (11682522)
2001
33
Histopathologic maturation of juvenile xanthogranuloma in a short period. (11358553)
2001
34
Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. (11318879)
2001
35
Primary angiitis of the central nervous system: an ante-mortem diagnosis. (11435655)
2000
36
Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia]. (11107528)
2000
37
Growth regulation, acid sphingomyelinase gene and genomic imprinting: lessons from an experiment of nature. (11310411)
2000
38
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. (10485912)
1999
39
Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered. (10024664)
1999
40
Aneurysmal fibrous histiocytoma: an unusual variant of cutaneous fibrous histiocytoma. (10461644)
1999
41
Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (9537341)
1998
42
Clustering the adhesion molecules VLA-4 (CD49d/CD29) in Jurkat T cells or VCAM-1 (CD106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilization. (9209507)
1997
43
Dorsal midline proboscis associated with diastematomyelia and tethered cord syndrome. Case report. (8814181)
1996
44
Primary adenosquamous carcinoma of the colon. (8823993)
1995
45
Opposable triphalangeal thumb: clinical features and results of treatment. (8169367)
1994
46
Inflammatory breast carcinoma (carcinoma erysipeloides): an easily overlooked diagnosis. (8286233)
1993
47
Neural arch stenosis and spinal cord injury in thanatophoric dysplasia. (1985437)
1991
48
Use of the dinitrophenyl hapten sandwich staining procedure (DHSS) to localize estrogen receptors in paraffin-embedded tissues. (1719072)
1991
49
Mycetoma due to Nocardia caviae. (3494691)
1987
50
Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. (6684724)
1983

Variations for Peripartum Cardiomyopathy

About this section

Expression for genes affiliated with Peripartum Cardiomyopathy

About this section
Search GEO for disease gene expression data for Peripartum Cardiomyopathy.

Pathways for genes affiliated with Peripartum Cardiomyopathy

About this section

GO Terms for genes affiliated with Peripartum Cardiomyopathy

About this section

Biological processes related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1temperature homeostasisGO:00016599.5ADRB1, DRD2

Sources for Peripartum Cardiomyopathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet